Page last updated: 2024-11-02

oxotremorine and Neurodegenerative Diseases

oxotremorine has been researched along with Neurodegenerative Diseases in 1 studies

Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
"Treatment with Oxotremorine-M significantly increased the level of phosphorylated HSF1 in all time points studied, without change of protein levels."1.48Heat shock protein (Hsp) regulation by muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus. ( Belluardo, N; Cappello, F; Frinchi, M; Mudò, G; Scaduto, P, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frinchi, M1
Scaduto, P1
Cappello, F1
Belluardo, N1
Mudò, G1

Other Studies

1 other study available for oxotremorine and Neurodegenerative Diseases

ArticleYear
Heat shock protein (Hsp) regulation by muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus.
    Journal of cellular physiology, 2018, Volume: 233, Issue:8

    Topics: Animals; Heat Shock Transcription Factors; Heat-Shock Proteins; Hippocampus; Male; Neurodegenerative

2018